Abstract
Complement protein biosynthesis has been a subject of study for over 100 years. In the 1890s, Metchinoff suggested that leukocytes were a source of complement1. Interest in the liver as a site of complement production was first generated by the experiments of Ehrlich and Morgenroth2, who demonstrated that complement, but not antibody, was depressed in sera of animals poisoned with phosphorus. Shortly thereafter, Muller found that perfusion of liver with serum led to an increase in complement activity in the effluate, and concluded that the liver was the site of complement synthesis3. In the late 1960s, Alper and coworkers4‘5 confirmed this observation that the liver was a major site of serum complement synthesis by studying a patient following liver transplantation; the electrophoretic form of C3 shifted from the recipient FS type to the donor SS type. The complete shift of C3 from recipient to donor type indicated that the liver synthesized at least 95% of the C3 found in serum4,5. Also in the 1960s, Thorbecke and her colleagues6-8 suggested that cell types of endodermal, mesodermal and ectodermal origin in several organs were capable of synthesizing proteins of the complement system. Application of modern molecular biological methods has confirmed that complement proteins are synthesized at multiple sites. In addition, studies of complement metabolism and mRNA expression in vivo9~n and in tissue culture12,13 indicate a role for complement produced at extrahepatic sites, especially in the immunopathogenesis of autoimmune injury. The functional importance of this extrahepatic complement production is supported by the elaborate tissue-specific and developmentally regulated controls of complement gene expression now recognized in several species.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Mechinoff, E. (1905). Immunity in Infective Disease, p. 59. (London-New York: Cambridge University Press)
Ehrlich, P. and Morgenroth, J. (1900). Ueber Haemolysine. Berlin Klin. Wochenschr., 37, 453–5
Muller, L. (1911). Zentralbl. Bacteriol. Parasiter. Infectionshr. Abt 1: Orig 57, 577
Alper, C. A., Johnson, A. M., Birtch, A. G. and Moore, R. D. (1969). Human C3: Evidence for the liver as the primary site of synthesis. Science, 163, 286–288
Alper, C. A., Raum, D., Awdeh, Z., Petersen, B. H., Taylor, P. D. and Starzl, T. E. (1980). Studies of hepatic synthesis in vivo of plasma proteins including orosomucoid, transferrin, alpha-1-antitrypsin, C8 and factor B. Clin. Immunol. Immunopathol., 16, 84–89
Thorbecke, G. J., Hochwald, G. M., vanFurth, L. R., Muller-Eberhard, H. J. and Jacobson, E. B. (1965). Problems in determining the sites of synthesis of complement components. In Wolstenholme, G. E. W. and Knight, J. (eds.), CIBA Symposium: Complement, pp. 99–119. (London: Churchill).
Stecher, V. J. and Thorbecke, G. J. (1967). Sites of synthesis of serum proteins. I. Serum proteins produced by macrophages in vitro. J. Immunol., 99, 643–652
Stecher, V. J. and Thorbecke, G. J. (1967). Sites of synthesis of serum proteins. III. Production of beta-l-C, beta-l-E and transferrin by primate and rodent cell lines. J. Immunol., 99, 660–662
Ruddy, S. and Colten, H. R (1974) Rheumatoid arthritis: Biosynthesis of complement proteins by synovial tissues. N. Engl. J. Med., 290, 1284–1288
Falus, A., Beuscher, H. U., Auerbach, H. S. and Colten, H. R. (1987). Constitutive and IL-1 regulated murine complement gene expression is strain and tissue specific. J. Immunol., 138, 856–860
Passwell, J., Schreiner, G. F., Nonaka, M., Beuscher, H. U. and Colten, H. R. (1988). Local extrahepatic expression of complement genes C3, factor B, C2 and C4 is increased in murine lupus nephritis. J. Clin. Invest., 82, 1676–1684
Colten, H. R. and Gitlin, J. D. (1990). Immunoproteins. In Handin, R. L, Lux, S. E. and Stossel, T. P. (eds.) Blood: Principles and Practice of Hematology. (Philadelphia: J. B. Lippincott) (In press)
Perlmutter, D. H. and Colten, H. R. (1988). Complement: Molecular genetics. In Gallin, J. I., Goldstein, I. M. and Snyderman, R. (eds.) Inflammation: Basic Principles and Clinical Correlates, pp. 75–88. (New York: Raven Press)
Ramadori, G., Tedesco, F., Bitter-Suermann, D. and Meyer zum Buschenfelde, K. H. (1985). Biosynthesis of the third (C3), eighth (C8), and ninth (C9) complement components by guinea pig hepatocyte primary cultures. Immunobiology, 170, 203–210
Morris, K. M., Aden, D. P., Knowles, B. B. and Colten, H. R. (1982). Complement biosynthesis by the human hepatoma derived cell line HepG2. J. Clin. Invest., 70, 906–913
Manthei, U., Strunk, R. C. and Giclas, P. C. (1984). Acute local inflammation alters synthesis, distribution and catabolism of the third component of complement (C3) in rabbits. J. Clin. Invest., 74, 424–433
Giclas, P. C, Strunk, R. C. and Manthei, U. (1985). The acute phase response of C3, C5, ceruloplasmin and C-reactive protein, induced by turpentine pleurisy in the rabbit. Am. J. Pathol, 120, 146–156
Zahedi, K. and Whitehead, A. S. (1989). Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation. J. Immunol., 143, 2880–2886
Katz, Y. and Strunk, R. C. (1989). IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts. J. Immunol., 142, 3862–3867
Perlmutter, D. H., Goldberger, G., Dinarello, C. A., Mizel, S. B. and Colten, H. R. (1986). Regulation of class III major histocompatibility complex (MHC) gene products by interleukin 1. Science, 232, 850–852
Perlmutter, D. H., Dinarello, C. A., Punsal, P. I. and Colten, H. R. (1986). Cachectin/tumor necrosis factor regulates hepatic acute phase gene expression. J. Clin. Invest., 78, 1349–1354
Katz, Y. and Strunk, R. C. (1988). Synthesis and regulation of complement protein factor H in human fibroblasts. J. Immunol., 141, 559–563
Katz, Y. and Strunk, R. C. (1989). Synthesis and regulation of C1 inhibitor in human skin fibroblasts. J. Immunol, 142, 2041–2045
Katz, Y. and Strunk, R. C. (1988). Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum., 31, 1365–1370
Katz, Y., Revel, M. and Strunk, R. C. (1989). Interleukin 6 stimulates synthesis of complement proteins factor B and C3 in human skin fibroblasts. Eur. J. Immunol., 19, 983–988
Katz, Y., Cole, F. S. and Strunk, R. C. (1988). Synergism between interferon-gamma and lipopolysaccharide for synthesis of factor B, but not C2, in human fibroblasts. J. Exp. Med., 167, 1–14
Cole, F. S. and Colten, H. R. (1988). Complement biosynthesis. In Rother, K. and Till, G. O. (eds.), The Complement System, pp. 44–70. (Berlin-Heidelberg: Springer-Verlag)
Kulics, J., Colten, H. R. and Perlmutter, D. H. (1990). Counter-regulatory effects of interferon-γ and endotoxin on expression of the human C4 genes. J. Clin. Invest., 85, 943–949
Cole, F. S., Matthews, W. J. Jr., Rossing, T. H., Gash, D. J., Lichtenberg, N. A. and Pennington, J. E. (1983). Complement biosynthesis by human bronchoalveolar macrophages. Clin. Immunol. Immunopathol., 27, 153–159
Whaley, K. (1980). Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J. Exp. Med., 151, 501–516
Strunk, R. C, Eidlen, D. M. and Mason, R. J. (1988). Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J. Clin. Invest., 81, 1419–1426
Al-Adnani, M. S. and McGee, J. O‘D. (1976). C1q production and secretion by fibroblasts. Nature, 263, 145–146
Reid, K. B. M. and Solomon, E. (1977). Biosynthesis of the first component of complement by human fibroblasts. Biochem. J., 167, 647–660
Strunk, R. C, Cole, F. S., Perlmutter, D. H. and Colten, H. R. (1985). Gamma interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. J. Biol. Chem., 260, 15280–15285
Strunk, R. C, Whitehead, A. S. and Cole, F. S. (1985). Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide. J. Clin. Invest., 76, 985–990
Barbey-Morel, C., Pierce, J. A., Campbell, E. J. and Perlmutter, D. H. (1987). Lipopolysaccharide modulates the expression of alpha-1-proteinase inhibitor and other serine proteinase inhibitors in human monocytes and macrophages. J. Exp. Med., 166, 1041–1054
Pennington, J. E., Matthews, W. J. Jr., Marino, J. T. Jr. and Colten, H. R. (1979). Cyclophosphamide and cortisone acetate inhibit complement biosynthesis by guinea pig bronchoalveolar macrophages. J. Immunol., 123, 1318–1321
Alpert, S. E., Pennington, J. E. and Colten, H. R. (1984). Synthesis of complement by guinea pig bronchoalveolar macrophages. Effect of acute and chronic infection with Pseudomonas aeruginosa. Am. Rev. Respir. Dis., 129, 66–71
De Ceulaer, C, Papazoglou, S. and Whaley, K. (1980). Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and synovial membrane cells from patients with rheumatoid arthritis. Immunology, 41, 37–43
Ramadori, G., Sipe, J. D. and Colten, H. R. (1985). Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J. Immunol., 135, 3645–3647
Reid, K. B. M. (1985). Molecular cloning and characterization of the complementary DNA and gene coding for the B-chain of subcomponent C1q of the human complement system. Biochem. J., 231, 729–735
Sellar, G. C. and Reid, K. B. M. (1990). Molecular cloning and alignment of the genes coding for the A, B, and C chains of human C1q of the serum complement system. Biochem. J. (In press)
Joumet, A. and Tosi, M. (1986). Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r. Biochem. J., 240, 783–787
Tosi, M. C, Duponchel, C., Meo, T. and Julier, C. (1987). Complete cDNA sequence of human complement C1s and close physical linkage of the homologous genes C1s and C1r. Biochemistry, 26, 8516–8524
Kusumoto, H., Hirosawa, S., Salier, J. P., Hagen, F. S. and Kurachi, K. (1988). Human genes for complement components C1r and C1s in a close tail-to-tail arrangement. Proc. Natl. Acad. Sci. USA, 85, 7307–7311
Sellar, G. C. and Reid, K. B. M. (1990). Molecular cloning and alignment of the genes coding for the A, B and C chains of human C1q of the serum complement system. Biochem. J. (In press)
Sellar, G. C, Goundis, D., McAdam, R. A., Solomon, E. and Reid, K. B. M. (1987). Cloning and chromosomal localization of human C1q A-chain. Identification of molecular defect in a C1q deficient patient. Complement, 4, 225
Morris, K. M., Colten, H. R. and Bing, D. H. (1978). The first component of complement (CI): A quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cells. J. Exp. Med., 148, 1007–1019
Colten, H. R., Borsos, T. and Rapp, H. J. (1966). In vitro synthesis of the first component of complement by guinea pig small intestine. Proc. Natl. Acad. Sci. USA, 56, 1158–1163
Colten, H. R., Gordon, J. M., Borsos, T. and Rapp, H. J. (1968). Synthesis of the first component of human complement in vitro. J. Exp. Med., 128, 595–604
Loos, M. (1983). Biosynthesis of the collagen-like C1q molecule and its receptor function of Fc and polyanionic molecules on macrophages. Curr. Top. Microbiol. Immunol., 102, 1–56
Al-Adnani, M. S. and McGee, J. O. (1976). C1q production and secretion by fibroblasts. Nature, 263, 145–146
Muller, W., Hanauske-Abel, H. and Loos, M. (1978). Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages. Evidence for an independent production of the CI subunits. J. Immunol., 121, 1578–1584
Bensa, M. C, Reboul, A. and Colomb, M. G. (1983). Biosynthesis in vitro of complement subcomponents C1q, C1s and CI-inhibitor by resting and stimulated human monocytes. Biochem. J., 216, 385–392
Loos, M., Martin, H. and Petry, F. (1989). The biosynthesis of C1q, the collagen-like and Fc-recognizing molecule of the complement system. Behring Inst. Mitt., 84, 32–41
Muller, W., Hanauski-Abel, H. and Loos, M. (1978). Reversible inhibition of C1q release from guinea pig macrophages by 2,2‘-dipyridyl. FEBS Lett., 90, 218–222
Beatty, D. W., Davis, A. E., Cole, F. S., Einstein, L. P. and Colten, H. R. (1981). Biosynthesis of complement by human monocytes. Clin. Immunol. Immunopathol., 18, 334–343
Einstein, L. P., Schneeberger, E. E. and Colten, H. R. (1976). Synthesis of the second component of complement by long-term primary cultures of human monocytes. J. Exp. Med., 143, 114–126
Littman, B. H., Hall, R. E. and Muchmore, A. V. (1983). Lymphokine and phorbol (PMA) regulation of complement (C2) synthesis using U937. Cell. Immunol., 76, 189–195
Alpert, S. E., Auerbach, H. S., Cole, F. S. and Colten, H. R. (1983). Macrophage maturation: Differences in complement secretion by marrow, monocyte and tissue macrophages detected with an improved hemolytic plaque assay. J. Immunol., 130, 102–107
Cole, F. S., Auerbach, H. S., Goldberger, G. and Colten, H. R. (1985). Tissue specific pretrans-lational regulation of complement production in human mononuclear phagocytes. J. Immunol., 134, 2610–2616
Hall, R. E. and Colten, H. R. (1977). Cell-free synthesis of the fourth component of guinea pig complement (C4): Identification of a precursor of serum C4 (pro-C4). Proc. Natl. Acad. Sci. USA, 74, 1707–1710
Fey, G., Odink, K. and Chapuis, R. M. (1980). Synthesis of the mouse complement component C4 (Ss-protein) by peritoneal macrophages: Kinetics of secretion and glycosylation of the subunits. Eur. J. Immunol., 10, 75–82
Schreiber, R. D. and Muller-Eberhard, H. J. (1974). Fourth component of human complement: description of a three polypeptide chain structure. J. Exp. Med., 140, 1324–1335
Whitehead, A. S., Goldberger, G., Woods, D. E., Markham, A. F. and Colten, H. R. (1983). Use of a cDNA clone for the fourth component of human complement for analysis of a genetic deficiency of C4 in guinea pig. Proc. Natl. Acad. Sci. USA, 80, 5387–5391
Carroll, M. C, Belt, K. T., Palsdottir, A. and Porter, R. R. (1984). Structure and organization of C4 genes. Phil. Trans. R. Soc., 306, 379–388
Carroll, M. C, Campbell, R. D., Bentley, D. R. and Porter, R. R. (1984). A molecular map of the human MHC complex class III region linking complement genes C4, C2 and factor B. Nature, 307, 237–241
Belt, K. T., Carroll, M. C. and Porter, R. R. (1984). The structural basis of the multiple forms of human complement component C4. Cell, 36, 907–1014
Yu, C. Y., Belt, K. T., Giles, C. M., Campbell, R. D. and Porter, R. R. (1986). Structural basis of the polymorphism of human complement components C4A and C4B gene size, reactivity and antigenicity. EMBO J., 5, 2873–2881
Schneider, P. M., Carroll, M. C, Alper, C. A., Rittner, C, Whitehead, A. S., Yunis, E. J. and Colten, H. R. (1986). Polymorphism of the human complement C4 and steroid 21-hydroxylase genes: restriction fragment length polymorphisms revealing structural deletions, homoduplica-tions and size variants. J. Clin. Invest., 78, 650–657
Awdeh, Z. L. and Alper, C. A. (1978). Inherited structural polymorphism of the fourth component of human complement. Proc. Natl. Acad. Sci. USA, 77, 3576–3580
Goldberger, G., Abraham, G. N., Williams, J. and Colten, H. R. (1980). NH2-terminal sequence analysis of pro-C4, the precursor of the fourth component of guinea pig complement. J. Biol. Chem., 255, 7071–7074
Goldberger, G. and Colten, H. R. (1980). Precursor complement protein (pro-C4) is converted in vitro to native C4 by plasmin. Nature, 286, 514–516
Parker, K. L., Capra, J. D. and Shreffler, D. C. (1980). Partial amino acid sequences of the murine fourth component of complement (C4): demonstration of homology with human C4 and identification of amino terminal subunit in pro-C4. Proc. Natl. Acad. Sci. USA, 77, 4275–4278
Carroll, M. C. and Porter, R. R. (1983). Cloning of a human complement C4 gene. Proc. Natl. Acad. Sci. USA, 80, 264–267
Ogata, R. T., Shreffler, D. C, Sepich, D. S. and Lilly, S. P. (1983). cDNA clone spanning the alpha-gamma subunit junction in the precursor of the murine fourth complement component (C4). Proc. Natl. Acad. Sci. USA, 80, 5061–5065
Karp, D. R. (1983). Post-translational modification of the fourth component of complement. Sulfation of the alpha chain. J. Biol. Chem., 258, 12745–12748
Karp, D. R. (1983). Post-translational modification of the fourth component of complement: Effect of tunicamycin and amino acid analogs on the formation of the internal thiol ester and disulfide bonds. J. Biol. Chem., 258, 14490–14495
Matthews, W. J., Goldberger, G., Marino, J. T., Einstein, L. P., Gash, D. J. and Colten, H. R. (1982). Complement proteins C2, C4, and factor B: effect of glycosylation on their secretion and catabolism. Biochem. J., 204, 839–846
Roos, M. H., Kornfeld, S. and Shreffler, D. C. (1980). Characterization of the oligosaccharide units of the fourth component of complement (Ss protein) synthesized by murine macrophages. J. Immunol., 124, 2860–2861
Chan, A. C, Mitchell, K. R., Munns, T. W., Karp, D. R. and Atkinson, J. P. (1983). Identification and partial characterization of the secreted form of the fourth component of human complement: evidence that it is different from the major plasma form. Proc. Natl. Acad. Sci. USA, 80, 268–272
Hortin, G., Chan, A. C, Fok, K. F., Strauss, A. W. and Atkinson, J. P. (1986). Sequence analysis of the COOH terminus of the alpha chain of the fourth component of human complement. Identification of the site of its extracellular cleavage. J. Biol. Chem., 261, 9065–9069
Roos, M. H., Atkinson, J. P. and Shreffler, D. C. (1978). Molecular characterization of the Ss and Sip (C4) proteins of the mouse H-2 complex: subunit composition, chain size polymorphism and an intracellular (pro-Ss) precursor. J. Immunol., 121, 1106–1115
Morris, K. M., Goldberger, G., Colten, H. R., Aden, D. P. and Knowles, B. B. (1982). Biosynthesis and processing of a human precursor complement protein, pro-C3, in a hepatoma-derived cell line. Science, 215, 399–400
Sackstein, R. and Colten, H. R. (1984). Molecular regulation of MHC class III (C4 and factor B) gene expression in mouse peritoneal macrophages. J. Immunol., 133, 1618–1626
Shreffler, D. C. (1976). The S region of the mouse major histocompatibility complex (H-2): Genetic variation and functional role in complement system. Transplant. Rev., 32, 140–167
Shreffler, D. C. (1982). MHC-linked complement components. In Parham, P. and Strominger, J. (eds.) Histocompatibility Antigens: Structure and Function, pp. 189–219. London: Chapman and Hall
Newell, S. L. and Atkinson, J. P. (1983). Biosynthesis of C4 by mouse peritoneal macrophages. II. Comparison of C4 synthesis by resident and elicited cell populations. J. Immunol., 130, 834–838
Rosa, P. A. and Shreffler, D. C. (1983). Cultured hepatocytes from mouse strains expressing high and low levels of the fourth component of complement differ in rate of synthesis of the protein. Proc. Natl. Acad. Sci. USA, 80, 2332–2336
Cox, B. J. and Robins, D. M. (1988). Tissue-specific variation in C4 and Sip gene regulation. Nucl. Acids Res., 16, 6857–6870
Rosa, P. A., Sepich, D. S., Robins, D. M. and Ogata, R. T. (1987). Constitutive expression of Slp genes in mouse strain B10. WR directed by C4 regulatory sequences. J. Immunol., 139, 1568–1577
Stavenhagen, J., Loreni, F., Hemenway, C, Kalff, M. and Robins, D. M. (1987). Molecular genetics of androgen-dependent and independent expression of mouse sex-limited protein. Mol. Cell.Biol., 7, 1716–1724
Bruisten, S. M, Demant, P. and Robins, D. M. (1989). Trans-regulatory genes affect Slpa and S1p° expression and act in a tissue-specific manner. Immunogenetics, 29, 340–345
Nakayama, K., Nonaka, M., Yokoyama, S., Yeul, Y. D., Pattanakitsakul, S-N. and Takahashi, M. (1987). Recombination of two homologous MHC class III genes of the mouse (C4 and Sip) that accounts for the loss of testosterone dependence of sex-limited protein expression. J. Immunol, 138, 620–627
Hemenway, C. and Robins, D. M. (1987). DNase I-hypersensitive sites associated with expression and hormonal regulation of mouse C4 and Sip genes. Proc. Natl. Acad. Sci. USA, 84, 4816–4820
Ishikawa, N., Nonaka, M., Wetsel, R. A. and Colten, H. R. (1990). Murine complement C2 and factor B genomic and cDNA cloning reveals different mechanisms for multiple transcripts of C2 and B. J. Biol. Chem., 265, 19040–19046
Bentley, D. R. (1986). Primary structure of human complement component C2: homology to two unrelated protein families. Biochem. J., 239, 339–345
Mole, J. E., Anderson, J. K., Davidson, E. A. and Woods, D. E. (1984). Complete primary structure of the zymogen of human complement factor B. J. Biol. Chem., 259, 3407–3412
Falus, A., Wakeland, E. K., McConnell, T. J., Gitlin, J. D., Whitehead, A. S. and Colten, H. R. (1987). DNA polymorphism of MHC III genes in inbred and wild mouse strains. Immunogenetics, 25, 290–298
Horiuchi, T., Macon, K. J., Kidd, V. J. and Volanakis, J. E. (1990). Translational regulation of complement protein C2 expression by differential utilization of the 5‘-untranslated region of mRNA. J. Biol. Chem., 265, 6521–6524
Einstein, L. P., Hansen, P. J., Ballow, M., Davis, A. E., Davis, J. S., Alper, C. A., Rosen, F. S. and Colten, H. R. (1977). Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3 deficient humans. J. Clin Invest., 60, 963–969
Sundstrom, S. A., Komm, B. S., Ponce-de-Leon, H., Yi, Z., Teuscher, C. and Lyttle, C. R. (1989). Estrogen regulation of tissue-specific expression of complement C3. J. Biol. Chem., 264, 16941–16947
Levi-Strauss, M. and Mallat, M. (1987). Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J. Immunol., 139, 2361–2366
Warren, H. B., Pantazis, P. and Davies, P. F. (1987). The third component of complement is transcribed and secreted by cultured human endothelial cells. Am. J. Pathol., 129, 9–13
Rothman, B. L., Merrow, M., Bamba, M., Kennedy, T. and Kreutzer, D. L. (1989). Biosynthesis of the third and fifth complement components by isolated human lung cells. Am. Rev. Respir. Dis., 139, 212–220
Nichols, W. K. (1984). LPS stimulation of complement (C3) synthesis by a human monocyte cell line. Complement, 1, 108–115
Goodrum, K. J. (1987). Complement component C3 secretion by mouse macrophage-like cell lines. J. Leukocyte Biol, 41, 295–301
Dieli, F., Lio, D., Sireci, G. and Salerno, A. (1988). Genetic control of C3 production by the S region of the mouse MHC. J. ImmunoGenet., 15, 339–343
Ferreira, A. and Nussenzweig, V. (1975). Genetic linkage between serum levels of the third component of complement and the H-2 complex. J. Exp. Med., 141, 513–517
Natsuume-Sakai, S., Hayarawa, J. I. and Takahashi, M. (1978). Genetic polymorphism of murine C3 controlled by a single codominant locus on chromosome 17. J. Immunol, 121, 491–498
DaSilva, F. P., Hoecker, G. E., Day, N. K., Vienne, D. and Rubinstein, P. (1978). Murine complement component 3: Genetic variation and linkage to H-2. Proc. Natl. Acad. Sci. USA, 75, 963–965
Whitehead, A. S., Solomon, E., Chambers, S., Bodmer, W. F., Povey, S. and Fey, G. (1982). Assignment of the structural gene for the third component of human complement to chromosome 19. Proc. Natl. Acad. Sci. USA, 79, 5021–5025
Khan, S. A. and Erickson, B. W. (1982). An equilibrium model of the metastable binding sites of alpha 2 macroglobulin and complement proteins C3 and C4. J. Biol. Chem., 257, 11864–11867
Iijima, M., Tobe, T., Sakamoto, T. and Tomita, M. (1984). Biosynthesis of the internal thioester bond of the third component of complement. J. Biochem, 96, 1539–15346
Auerbach, H. S., Burger, R., Dodds, A. and Colten, H. R. (1990). Molecular basis of complement C3 deficiency in guinea pigs. J. Clin, Invest., 86, 96–106
Alper, C. A. and Rosen, F. S. (1971). Genetic aspects of the complement system (review). Adv. Immunol, 14, 251–290
Peters, D. K., Martin, A., Weinstein, A., Cameron, J. S., Barratt, T., Ogg, C. S. and Lachmann, P. J. (1972). Complement metabolism in membranoproliferative nephritis. Clin. Exp. Immunol., 11, 311–320
Perlmutter, D. H., Daniels, J. D., Auerbach, H. S., DeSchryver-Kecskemeti, K., Winter, H. S. and Alpers, D. H. (1989). The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J. Biol. Chem., 264, 9485–9490
Ramadori, G., Sipe, J. D., Dinarello, C. A., Mizel, S. B. and Colten, H. R. (1985). Pretransla-tional modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J. Exp. Med., 162, 930–942
Minta, J. O. (1988). Synthesis of complement factor B by the human monocyte U-937 cell line. Augmentation by immunostimulatory agents. J. Immunol., 141, 1636–1641
Nonaka, M., Ishikawa, N., Passwell, J., Natsuume-Sakai, S. and Colten, H. R. (1989). Tissue specific initiation of murine complement factor B mRNA transcription. J. Immunol., 142, 1377–1382
Circolo, A., Pierce, G. F., Katz, Y. and Strunk, R. C. (1990). Anti-inflammatory effects of polypeptide growth factors. Platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor inhibit the cytokine-induced expression of the alternative complement pathway activator factor B in human fibroblasts. J. Biol. Chem., 265, 5066–5071
Katz, Y. and Strunk, R. C. (1990). Enhanced synthesis of factor B induced by tumor necrosis factor in human skin fibroblasts is decreased by IL-4. J. Immunol., 144, 4675–4680
Perlmutter, D. H. (1989). Distinct mediators and mechanisms regulate human acute phase gene expression. In Purdue, M. L., Feramisco, J. R. and Lindquest, S. (eds.) Stress Induced Proteins, pp. 257–274 (New York: Alan R. Liss, Inc.)
Cook, K. S., Min, H. Y., Johnson, D., Chaplinsky, R. J., Flier, J. S., Hunt, C. R. and Spiegelman, B. M. (1987). Adipsin: A circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science, 237, 402–405.
Bentley, C, Fries, W. and Brade, V. (1978). Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea pig peritoneal macrophages in vitro. Immunology, 35, 971–980
Barnum, S. R. and Volanakis, J. E. (1985). In vitro biosynthesis of complement protein D by U937 cells. J. Immunol., 134, 1799–1803
Rosen, B. S., Cook, K. S., Yaglom, J., Groves, D. L., Volanakis, J. E., Damm, D., White, T. and Spiegelman, B. M. (1989). Adipsin and complement factor D activity: An immune-related defect in obesity. Science, 244, 1483–1487
Flier, J. S., Cook, K. S., Usher, P. and Spiegelman, B. M. (1987). Severely impaired adipsin expression in genetic and acquired obesity. Science, 237, 405–408
Piatt, K. A., Min, H. Y., Ross, S. R. and Spiegelman, B. M. (1989). Obesity-linked regulation of the adipsin gene promoter in transgenic mice. Proc. Natl. Acad. Sci. USA, 86, 7490–7494
White, T., Damm, D., Brown, R., Hancock, N., Rosen, B., Spiegelman, B. M., Lowell, B. and Flier, J. (1989). Isolation and characterization of cDNA clones for human complement factor D. Complement Inflamm., 6, 415 (abstract)
Barnum, S. R. and Volanakis, J. E. (1985). Biosynthesis of complement protein D by HepG2 cells: A comparison of D produced by HepG2 cells, U937 cells and blood monocytes. Eur. J. Immunol., 15, 1148–1151
Reid, K. B. M. unpublished
Fames, T. C. and Atkinson, J. P. (1989). Biosynthesis of properdin. J. Immunol, 142, 842–847
Goundis, D, and Reid, K. B. M. (1988). Properdin, the terminal complement components, thrombospondin and circumsporozoite protein of malarial parasites contain similar sequence motifs. Nature, 335, 82–85
Goundis, D. and Reid, K. B. M. (1987). Biosynthesis of complement proteins by the U937 cell line. Biochem. Soc. Trans., 15, 650–651
D‘Eustachio, P., Kristensen, T., Wetsel, R. A., Riblet, R., Taylor, B. A. and Tack, B. F. (1986). Chromosomal location of the genes encoding complement components C5 and factor H in the mouse. J. Immunol., 137, 3990–3995
Wetsel, R. A., Lemons, R. S., LeBeau, M. M., Barnum, S. R., Noack, D. and Tack, B. F. (1988). Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9. Biochemistry, 27, 1474–1482
Wheat, W. H., Wetsel, R., Falus, A., Tack, B. F. and Strunk, R. C. (1987). The fifth component of complement (C5) in the mouse. Analysis of the molecular basis for deficiency. J. Exp. Med., 165, 1442–1447
Colten, H. R. (1972). Ontogeny of the human complement system: In vitro biosynthesis of individual complement components by fetal tissue. J. Clin. Invest., 51, 725–730
Levy, N. L., Snyderman, R., Ladda, R. L. and Lieberman, R. (1973). Cytogenetic engineering in vivo: Restoration of biologic complement activity to C5-deficient mice by intravenous inoculation of hybrid cells. Proc. Natl. Acad. Sci. USA, 70, 3125–3129
Ooi, Y. M. and Colten, H. R. (1979). Biosynthesis and post-synthetic modification of a precursor (pro-C5) of the fifth component of mouse complement (C5). J. Immunol., 123, 2494–2498
Hetland, G., Johnson, E. and Aasebo, U. (1986). Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro. Scand. J. Immunol., 24, 603–608
Kohler, P. F. (1973). Maturation of the human complement system. I. Onset time and sites of fetal C1q, C4, C3, and C5 synthesis. J. Clin. Invest., 52, 671–677
Sundsmo, J. S. and Gotze, O. (1981). Human monocyte spreading by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading. J. Exp. Med., 154, 763–777
Curd, J. G., Sundsmo, J. S., Kolb, W. P., Bluestein, H. G. and Muller-Eberhard, H. J. (1978). Neoantigen of the membrane attack complex of human complement. Arthritis Rheum., 21, 177–182
Reed, W., Roubey, R. A. S., Dalzell, J. G., Matteucci, B. M., Myones, B. L., Hunt, S. W., Kolb, W. P and Ross, G. D. (1990). Synthesis of complement component C5 by human B and T lymphoblastoid cell lines. Immunogenetics, 31, 145–151
Lundwall, A. B., Wetsel, R. A., Kristensen, T., Whitehead, A. S., Woods, D. E., Ogden, R. C, Colten, H. R. and Tack, B. F. (1985). Isolation and sequence analysis of a cDNA clone encoding the fifth complement component (C5). J. Biol. Chem., 260, 2108–2112
Haviland, D. L., Haviland, J. C, Fleischer, D. T., Hunt, A. and Wetsel, R. A. (1991). Complete cDNA sequence of human complement pro-C5. Evidence of truncated transcripts derived from a single copy gene. J. Immunol., 146, 362–368
Haefliger, J-A., Tschopp, J., Vial, N. and Jenne, D. E. (1989). Complete primary structure and functional characterization of the sixth component of the human complement system. J. Biol. Chem., 264, 18041–18051
DiScipio, R. G., Chakravarti, D. N., Muller-Eberhard, H. J. and Fey, G. H. (1988). The structure of human complement component C7 and C5b-7 complex. J. Biol. Chem., 263, 549–560
Rao, A. G., Howard, O. Z. M., Ng, S. C, Whitehead, A. S., Colten, H. R. and Sodetz, J. M. (1987). Complementary DNA and derived amino acid sequence for the a subunit of human complement protein C8: Evidence for the existence of a separate a subunit mRNA. Biochemistry, 26, 3556–3564
Howard, O. Z. M., Rao, A. G. and Sodetz, J. M. (1987). Complementary DNA and derived amino acid sequence of the β-subunit of C8: identification of a close structural and ancestral relationship to the α-subunit and C9. Biochemistry, 26, 3565–3570
Ng, S. C. and Sodetz, J. M. (1987). Biosynthesis of C8 by hepatocytes: Differential expression and intracellular association of the α-γ and β subunits. J. Immunol., 139, 3021–3027
Ng, S. C, Rao, A. G., Howard, O. M. Z. and Sodetz, J. M. (1987). The eighth component of human complement: Evidence that it is an oligomeric serum protein assembled from products of three different genes. Biochemistry, 26, 5229–5233
DiScipio, R. G., Gehring, M. R., Podack, E. R., Kan, C. C, Hugh, T. E. and Fey, G. H. (1984). Nucleotide sequence of human complement component C9. Proc. Natl. Acad. Sci. USA, 81, 7298–7302
Stanley, K. K., Kocher, H. P., Luzio, J. P., Jackson, P. and Tschopp, J. (1985). The sequence and topology of human complement component C9. EMBO J., 4, 375–383
Pettersen, H. B., Johnson, E. and Hetland, G. (1987). Human alveolar macrophages synthesize active complement components C6, C7 and C8 in vitro. Scand. J. Immunol., 25, 567–570
Tedesco, F., Densen, P., Villa, M. A., Presani, G., Roncelli, L. and Rosso Di San Secondo, V. E. M. (1986). Functional C8 associated with human platelets. Clin. Exp. Immunol., 66, 472–480
Houle, J. J., Leddy, J. P. and Rosenfeld, S. I. (1989). Secretion of the terminal complement proteins, C5-C9, by human platelets. Clin. Immunol. Immunopathol., 50, 385–393
Kaufman, K. M., Snider, J. V., Spurr, N. K., Schwartz, C. E. and Sodetz, J. M. (1989). Chromosomal assignment of genes encoding the α, β, and γ subunits of human complement protein C8: Identification of a close physical linkage between the α and the β loci. Genomics, 5, 475–480
Densen, P. and McRill, C. M. (1987). Differential expression of C8 subunits: Primary role of C8 beta. Clin. Res., 35, 613A
Goldberger, G., Arnaout, M. A., Aden, D., Kay, R., Rits, M. and Colten, H. R. (1984). Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines. J. Biol. Chem., 259, 6492–6497
Munoz-Canoves, P., Tack, B. F. and Vik, D. P. (1989). Analysis of complement factor H mRNA expression: Dexamethasone and IFN-7 increase the level of H in L cells. Biochemistry, 28, 9891–9897
Brooimans, R. A., Hiemetra, P. S., van der Ark, A. A. J., Sim, R. B., van Es, L. A. and Daha, M. R. (1989). Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-7. J. Immunol, 142, 2024–2030
Lappin, D. F. and Whaley, K. (1990). Interferon-induced transcriptional and post-transcrip-tional modulation of factor H and C4 binding-protein synthesis in human monocytes. Biochem. J., 271, 767–772
Malhotra, V. and Sim, R. B. (1985). Expression of complement factor H on the cell surface of the human monocytic cell line U937. Eur. J. Immunol, 15, 935–941
Devine, D. V. and Rosse, W. F. (1987). Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc. Natl. Acad. Sci USA, 84, 5873–5877
Gitlin, D. and Biasucci, A. (1969). Development of γG, γA, γM, β1C/β1A, CI esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha-1-antitrypsin, orosomucoid, beta-lipoprotein, alpha-2-macroglobulin, and prealbumin in the human conceptus. J. Clin. Invest., 48, 1433–1436
Johnson, A. M., Alper, C. A., Rosen, R. S. and Graig, J. M. (1971). C1 inhibitor: Evidence for decreased hepatic synthesis in hereditary angioneurotic edema. Science, 173, 553–554
Yeung Laiwah, A. C, Jones, L., Hamilton, A. O. and Whaley, K. (1985). Complement subcomponent C1 inhibitor synthesis by human monocytes. Biochem. J., 226, 199–205
Bensa, J. C, Reboul, J. A. and Colomb, M. G. (1983). Biosynthesis in vitro of complement subcomponents C1q, C1s and CI-inhibitor by resting and stimulated human monocytes. Biochem. J., 216, 385–392
Schmaier, A. H., Smith, P. M. and Colman, R. W. (1985). Platelet C1 inhibitor. A secreted alpha-granule protein. J. Clin. Invest., 75, 242–250
Goldberger, G., Bruns, G. A. P., Rits, M., Edge, M. D. and Kwiatkowski, D. J. (1987). Human complement factor I: Analysis of cDNA-derived primary structure and assignment of its gene to chromosome 4. Biochemistry, 262, 10065–10071
Catterall, C. F., Lyons, A., Sim, R. B., Day, A. J. and Harris, T. J. R. (1987). Characterization of the primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones. Biochem. J., 242, 849–856
Lublin, D. M. and Atkinson, J. P. (1989). Decay-accelerating factor and membrane cofactor protein. Curr. Top. Microbiol. Immunol, 153, 123–125
Bora, N. S., Lublin, D. M., Kumar, B. V., Hockett, R. D., Holers, V. M. and Atkinson, J. P. (1989). Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3 ‘end of the C3b/C4b receptor gene. J. Exp. Med., 169, 597–602
Caras, I. W., Weddell, G. N., Davitz, M. A., Nussenzweig, V. and Martin, D. W. (1987). Signal for attachment of a phospholipid membrane anchor in decay-accelerating factor. Science, 238, 1280–1283
Medof, M. E., Lublin, D. M., Holers, V. M., Ayers, D. J., Getty, R. R., Leykam, J. F., Atkinson, J. P. and Tykocinski, M. L. (1987). Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. USA, 84, 2007–2011
Lublin, D. M., Krsek-Staples, J., Pangburn, M. K. and Atkinson, J. P. (1986). Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor. J. Immunol., 137, 1629–1635
Medof, M. E., Walter, E. I., Roberts, W. L., Haas, R. and Rosenberry, T. L. (1986). Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry, 25, 6740–6747
Tykocinski, M. L., Shu, H. K., Ayers, D. J., Walter, E. I., Getty, R. R., Groger, R. K., Hauer, C. A. and Medof, M. E. (1988). Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3 ‘end sequence of decay-accelerating factor’s mRNA. Proc. Natl. Acad. Sci. USA, 85, 3555–3559
Kushner, I. (1982). The phenomenon of the acute phase response. (Review). Ann. NY Acad. Sci., 389, 39–48
St. John Sutton, M. B., Strunk, R. C. and Cole, F. S. (1986). Regulation of synthesis of the third component of complement and factor B in cord blood monocytes by lipopolysaccharide. J. Immunol., 136, 1366–1372
Beutler, B., Krochin, N., Milsark, I. W., Leudke, C. and Cerami, A. (1986). Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science, 232, 977–980
Dinarello, C. A. (1984). Interleukin 1. Rev. Infect. Dis., 6, 51–95
Beuscher, H. U., Nickells, M. W. and Colten, H. R. (1988). The precursor of interleukin-la is phosphorylated at residue serine 90. J. Biol. Chem., 263, 4023–4028
Kurt-Jones, E. A., Beller, D. L, Mizel, S. B. and Unanue, E. R. (1985). Identification of a membrane-associated interleukin 1 in macrophages. Proc. Natl. Acad. Sci. USA, 82, 1204–1208
Giri, J. G., Lomedico, P. T. and Mizel, S. B. (1985). Studies on the synthesis and secretion of interleukin 1.1. A 33,000 m.w. precursor for interleukin 1. . J. Immunol., 134, 343–349
Perlmutter, D. H., Colten, H. R., Adams, S. P., May, L. T., Sehgal, P. B. and Fallon, R. J. (1989). A cytokine-selective defect in interleukin-1 β mediated acute phase gene expression in a subclone of the human hepatoma cell line (HepG2). J. Biol. Chem., 264, 7669–7674
Nonaka, M., Gitlin, J. D. and Colten, H. R. (1989). Regulation of human and murine complement: Comparision of 5’ structural and functional elements regulating human and murine complement factor B gene expression. Mol. Cell. BioChem., 89, 1–14
Beuscher, H. U., Fallon, R. J. and Colten, H. R. (1987). Macrophage membrane interleukin 1 regulates the expression of acute phase proteins in human hepatoma Hep3B cells. J. Immunol., 139, 1896–1901
Baumann, H., Onorato, V., Gauldie, J. and Jahreis, G. P. (1987). Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte-stimulating factors and monokines in rat hepatoma cells. J. Biol. Chem., 262, 9756–9768
Strunk, R. S., Tashjian, A. H. and Colten, H. R. (1975). Complement biosynthesis in vitro by rat hepatoma cell strains. J. Immunol., 114, 331–335
Wu, L-C, Morley, B. J. and Campbell, R. D. (1987). Cell-specific expression of the human complement protein factor B gene: Evidence for the role of two distinct 5‘-flanking elements. Cell, 48, 331–412
Beutler, B. and Cerami, A. (1989). The biology of cachectin/TNF-a primary mediator of the host response. Ann. Rev. Immunol., 7, 625–656
Gauldie, J., Richards, C, Harnish, D., Landsdorp, P. and Baumann, H. (1987). Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA, 84, 7251–7255
Kishimoto, T. K., Larson, R. S., Corbi, A. L., Dustin, M. L., Stauton, D. E. and Springer, T. A. (1989). The leukocyte integrins. Adv. Immunol. 46, 149–182
Akira, S., Hirano, T., Taga, T. and Kishimoto, T. (1990). Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J., 4, 2860–2867
Baumann, H., Isseroff, H., Latimer, J. J. and Jahreis, G. P. (1988). Phorbol ester modulates interleukin 6-and interleukin 1-regulated expression of acute phase plasma proteins in hepatoma cells. J. Biol. Chem., 263, 17390–17396
Miura, N., Prentice, H. L., Schneider, P. M. and Perlmutter, D. H. (1987). J. Biol. Chem., 262, 7298–7305
Ripoche, J., Mitchell, A., Erdei, A., Madin, C., Moffatt, B., Mokoena, T., Gordon, S. and Sim, R. B. (1988). Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture. J. Exp. Med., 168, 1917–1922
Peters, M. G., Ambrus, J. L., Fauci, A. S. and Brown, E. J. (1988). The Bb fragment of complement factor B acts as a cell growth factor. J. Exp. Med., 168, 1225–1235
Strunk, R. C. and Colten, H. R. (1985). Regulation of complement synthesis in mononuclear phagocytes. In Filkins, J. P. and Reichard, S. M. (eds.) The Reticulo-Endothelial System: A Comprehensive Treatise, pp. 25–46. (New York: Plenum Press)
Celada, A., Klemsz, M. J. and Maki, R. A. (1989). Interferon-γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-Aβ, tumour necrosis factor and complement component C3 in mouse macrophages. Eur. J. Immunol., 19, 1103–1109
Urbach, G. and Cinader, B. (1966). Hormonal control of MuBl concentration. Proc. Soc. Exp. Biol. Med., 122, 779–782
Churchill, W. H., Weintraub, R. M, Borsos, T. and Rapp, H. J. (1967). Mouse complement: The effect of sex hormones and castration on two of the late-acting components. J. Exp. Med., 125, 657–672
Ecker, E. E. and Rees, H. M. (1922). Effect of hemorrhage on complement of blood. J. Infect. Dis., 31, 361–367
Alper, C. A. and Propp, R. R. (1968). Genetic polymorphism of the third component of human complement. J. Clin. Invest., 47, 2181–2191
Sundstrom, S. A., Komm, B. S., Xu, Q., Boundy, V. and Lyttle, C. R. (1990). The stimulation of uterine complement component C3 gene expression by antiestrogens. Endocrinology, 126, 1449–1456
Isaacson, K. B., Coutifaris, C., Garcia, C-R. and Lyttle, C. R. (1989). Production and secretion of complement component 3 by endometriotic tissue. J. Clin. Endocrinol. Metab., 69, 1003–1009
Shreffler, D. C. and David, C. S. (1975). The H-2 major histocompatibility complex and the I immune response region: Genetic variation, function and organization. Adv. Immunol., 20, 125–195
Levi-Strauss, M., Tosi, M., Steinmetz, M., Klein, J. and Meo, T. (1985). Multiple duplications of complement C4 gene correlate with H-2-controlled testosterone-independent expression of its sex-limited isoform, C4-Slp. Proc. Natl. Acad. Sci. USA, 82, 1746–1750
Loreni, F., Stavenhagen, J., Kalff, M. and Robins, D. M. (1988). A complex androgen-responsive enhancer resides 2 kilobases upstream of the mouse Sip gene. Mol. Cell. Biol., 8, 2350–2360
Hourcade, D., Holers, V. M. and Atkinson, J. P. (1989). The regulators of complement activation (RCA) gene cluster. Adv. Immunol., 45, 381–416
Vedeler, C. A., Scarpini, E., Beretta, S., Doronzo, R. and Matre, R. (1990). The ontogenesis of FCγ receptors and complement receptors CR1 in human peripheral nerves. Acta Neuropathol., 80, 35–40
Kubota, Y., Gaither, T. A., Cason, J., O’shea, J. J. and Lawley, T. J. (1987). Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells. J. Immunol, 138, 1137–1142
Ross, G. D. and Medof, M. E. (1985). Membrane complement receptors specific for bound fragments of C3. Adv. Immunol., 37, 217–267
Todd, R. F. and Schlossman, S. F. (1984). Differential antigens on human monocytes and macrophages defined by monoclonal antibodies. In Volkman, A. (ed.) Mononuclear Phagocyte Biology, pp. 129–149. (New York: Marcell Dekker)
Schwarting, R., Stein, H. and Wang, C. Y. (1985). The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. Blood, 65, 974–983
LeBien, T. W. and Kersey, J. H. (1980). A monoclonal antibody (TA-1) reactive with human T lymphocytes and monocytes. J. Immunol., 125, 2208–2214
Miller, L. J., Schwarting, R. and Springer, T. A. (1986). Regulated expression of the Mac-1, LFA-1, pl50,95 glycoprotein family during leukocyte differentiation. J. Immunol., 137, 2891–2900
Nicholson-Weller, A., Burge, J., Fearon, D. T., Weller, P. F. and Austen, K. F. (1982). Isolation of a human erythrocyte membrane glycoprotein with decay accelerating activity for C3 convertases of the complement system. J. Immunol., 129, 184–189
Pangburn, M. K., Schreiber, R. D. and Muller-Eberhard, H. J. (1983). Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc. Natl. Acad. Sci. USA, 80, 5430–5434
Kinoshita, T., Medof, M. E., Silber, R. and Nussenzweig, V. (1985). Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J. Exp. Med., 162, 75–92
Nicholson-Weller, A., March, J. P., Rosen, C. E., Spicer, D. B. and Austen, K. F. (1985). Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system. Blood, 65, 1237–1244
Lublin, D. M. and Atkinson, J. P. (1989). Decay-accelerating factor and membrane cofactor protein. Curr. Top. Microbiol. Immunol., 153, 123–145
McNearney, T., Ballard, L., Seya, T. and Atkinson, J. P. (1989). Membrane cofactor protein of complement is present on human fibroblast, epithelial and endothelial cells. J. Clin. Invest., 84, 538–635
Asch, A. S., Kinoshita, T., Jaffe, E. A. and Nussenzweig, V. (1986). Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J. Exp. Med., 163, 221–226
Medof, M. E., Walter, E. I., Rutgers, J. L., Knowles, D. M. and Nussenzweig, V. (1987). Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J. Exp. Med., 165, 848–864
Cole, J. L., Housely, G. A., Dykman, T. R., MacDermott, R. P. and Atkinson, J. P. (1985). Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc. Natl. Acad. Sci. USA, 82, 859–863
Seya, T., Ballard, L. L., Bora, N. S., Kumar, B. V., Cui, W. and Atkinson, J. P. (1988). Distribution of membrane cofactor protein (MCP) of complement on human peripheral blood cells. Eur. J. Immunol., 18, 1289–1294
Mclntyre, J. A., Faulk, W. P., Verhulst, S. J. and Colliver, J. A. (1983). Human tropho-blast-lymphocyte cross-reactive (TLX) antigens define a new alloantigen system. Science, 222, 1135–1137
Sugita, Y., Nakano, Y. and Tomita, M. (1988). Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. J. Biochem. (Tokyo), 104, 633–637
Rollins, S. A. and Sims, P. J. (1990). The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immunol., 144, 3478–3483
Nose, M., Katoh, M., Okada, N., Kyogoku, M. and Okada, H. (1990). Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology, 70, 145–149
Sims, P. J., Rollins, S. A. and Wiedmer, T. (1989). Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex. J. Biol. Chem., 264, 19228–19235
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Colten, H.R., Strunk, R.C. (1993). Synthesis of complement components in liver and at extrahepatic sites. In: Whaley, K., Loos, M., Weiler, J.M. (eds) Complement in Health and Disease. Immunology and Medicine, vol 20. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2214-6_4
Download citation
DOI: https://doi.org/10.1007/978-94-011-2214-6_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4981-8
Online ISBN: 978-94-011-2214-6
eBook Packages: Springer Book Archive